![Nxera Team](/_next/image?url=https%3A%2F%2Fsosei-heptares.ams3.cdn.digitaloceanspaces.com%2F_2000xAUTO_crop_center-center_none%2FNxera-Team.jpeg&w=3840&q=75)
Team
Our management team, board and scientific advisory board have vast experience in the global pharma industry and provide a wealth of expertise.
Executive Officers
Board of Directors
![A portrait of Mr. Tomohiro Tohyama](/_next/image?url=https%3A%2F%2Fsosei-heptares.ams3.cdn.digitaloceanspaces.com%2F_600xAUTO_crop_center-center_none%2FMr-Tomohiro-Tohyama.png&w=3840&q=75)
Mr. Tomohiro Tohyama
External Independent Director
Tomohiro is a partner at TMI Associates, which he co-founded in October 1990. Having entered the Legal Training and Research Institute, Supreme Court of Japan in April 1978 and registered with Daiichi Tokyo Bar Association in April 1980, he joined Nishimura and Sanada Law Office in April 1980, becoming a partner in August 1985.
Tomohiro has also held positions at law firms Mason & Sloane, LLP, Pollock, Bloom & Dekom and Pryor, Cashman, Sherman & Flynn in the U.S. He has been external corporate auditor of Nippon Shikizai, Inc. since November 1999 and external director and Audit and Supervising Committee Member since May 2016, Outside Statutory Auditor of WOWOW INC. since June 2016, and external director of Trust Capital Co., Ltd. since May 2016.
Tomohiro joined the Board of Directors of Nxera Pharma in June 2011.